EUVIMEDSkopri EUVIMED
Crossref

Dihydrotanshinone Alleviates Lipopolysaccharide‐Induced Acute Lung Injury by Targeting NEK7 to Inhibit NLRP3 Inflammasome Activation

Xiaodong Huang, Liting Huang, Xinghua Ni, Qin-Qin Wang, Lina Liu, Yufang Shen, Linyu Xiao, Shilin Yang, Renyikun Yuan iD, Xin-Xing Li, Hongwei Gao iD

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70137 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Xiaodong Huang and 10 co-authors. Institution: Engineering Research Center of Innovative Drugs for Traditional Chinese Medicine and Zhuang & Yao Medicine, Ministry of Education, Nanning, China. Major MEDLINE topics: NLR Family, Pyrin Domain-Containing 3 Protein, NIMA-Related Kinases, Acute Lung Injury, Inflammasomes. 49 references. Funded by: Guangxi Distinguished Youth Science Foundation Project, Bagui Youth Outstanding Talent Cultivation Project, Project of Guangxi Young Qihuang Scholar.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Acute lung injury (ALI) carries high mortality with limited treatment options. Dihydrotanshinone (DHT), a bioactive component of Radix Salviae Miltiorrhizae , exhibits anti‐inflammatory properties, though its molecular targets remain unclear. Given the critical role of NIMA‐related kinase 7 (NEK7)‐mediated NOD‐like receptor family pyrin domain containing 3 (NLRP3) inflammasome activation in inflammatory diseases, this study investigated DHT's anti‐inflammatory effects through NEK7–NLRP3 regulation. In vitro, lipopolysaccharide (LPS) + ATP‐stimulated macrophages were used to activate the NLRP3 inflammasome. In vivo, ALI was induced in BALB/c mice via intratracheal LPS instillation (4 mg/kg). NEK7 knockdown was achieved through intravenous and intranasal delivery of NEK7 siRNA. Protein expression of NEK7–NLRP3 components was analyzed in both models. Results indicated that LPS + ATP stimulation significantly upregulated NEK7‐NLRP3 inflammasome components (NEK7, NLRP3, c‐caspase‐1, c‐IL‐1β) in macrophages and ALI tissues. DHT inhibited NEK7‐NLRP3 complex formation, suppressing inflammasome assembly and activation. NEK7 knockdown eliminated IL‐1β secretion in vitro and alleviated ALI in vivo. DHT treatment prevented pulmonary injury and reduced neutrophil infiltration. This study identifies DHT as a novel NEK7‐NLRP3 inflammasome inhibitor, demonstrating its therapeutic potential for ALI treatment. These findings provide a new pharmacological approach targeting NEK7‐mediated inflammasome activation in inflammatory lung diseases.

Subjects

MeSH terms (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinNIMA-Related KinasesAcute Lung InjuryInflammasomesPhenanthrenesAnti-Inflammatory AgentsFuransAnimalsLipopolysaccharidesMice, Inbred BALB CMiceMaleMacrophagesInterleukin-1betaRAW 264.7 CellsQuinones

Author keywords

DihydrotanshinoneNEK7NLRP3 inflammasomeacute lung injury

Substances

NLR Family, Pyrin Domain-Containing 3 ProteinNIMA-Related KinasesLipopolysaccharidesInflammasomesNek7 protein, mousedihydrotanshinone INlrp3 protein, mousePhenanthrenesInterleukin-1betaAnti-Inflammatory Agents

Authors and institutions

  • Engineering Research Center of Innovative Drugs for Traditional Chinese Medicine and Zhuang & Yao Medicine, Ministry of Education, Nanning, China.
  • College of Pharmacy, Guangxi University of Chinese Medicine, Nanning, China.
  • College of Pharmacy, Fudan University, Shanghai, China.

ORCID profiles: Renyikun Yuan, Hongwei Gao

Funding

  • Guangxi Distinguished Youth Science Foundation Project
  • Bagui Youth Outstanding Talent Cultivation Project
  • Project of Guangxi Young Qihuang Scholar
  • Young Talent Research Funding Project
  • Doctoral Foundation of Guangxi University of Chinese Medicine
  • Guangxi Science and Technology Base and Talent Project
  • Guangxi University of Chinese Medicine Outstanding Youth Project
  • Guangxi Youth Science and Technology Talent Support Project

Cite

APA

Huang, X., Huang, L., Ni, X., Wang, Q. Q., Liu, L., Shen, Y., Xiao, L., Yang, S., Yuan, R., Li, X. X., & Gao, H. (2026). Dihydrotanshinone Alleviates Lipopolysaccharide‐Induced Acute Lung Injury by Targeting NEK7 to Inhibit NLRP3 Inflammasome Activation. Phytotherapy Research. https://doi.org/10.1002/ptr.70137

Vancouver

Huang X, Huang L, Ni X, Wang QQ, Liu L, Shen Y, et al. Dihydrotanshinone Alleviates Lipopolysaccharide‐Induced Acute Lung Injury by Targeting NEK7 to Inhibit NLRP3 Inflammasome Activation. Phytotherapy Research. 2026. doi:10.1002/ptr.70137

BibTeX
@article{Huang2026,
  author = {Huang, Xiaodong and Huang, Liting and Ni, Xinghua and Wang, Qin-Qin and Liu, Lina and Shen, Yufang and Xiao, Linyu and Yang, Shilin and Yuan, Renyikun and Li, Xin-Xing and Gao, Hongwei},
  title = {Dihydrotanshinone Alleviates Lipopolysaccharide‐Induced Acute Lung Injury by Targeting NEK7 to Inhibit NLRP3 Inflammasome Activation},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70137}
}
Start for free →